IGC Pharma Expands AI Platform With Advanced Diagnostic Model for Alzheimer's and Dementia Detection
Dementia affects over 55 million people worldwide, causing progressive cognitive decline, memory loss, and behavioral changes. Despite its widespread impact, current diagnostic methods often rely on invasive procedures, expensive imaging, and subjective clinical assessments, leading to high rates of misdiagnosis and delayed treatment.
IGC Pharma's cutting-edge AI model is designed to address these challenges by integrating vast clinical datasets and leveraging deep learning algorithms to distinguish between the different diseases that cause dementia. By reducing false negatives and misdiagnoses, the model has the potential to significantly improve early detection, ensuring patients receive the right treatment at the right time.
The AI model is being trained on multi-modal clinical data from leading public research databases, including the National Alzheimer's Coordinating Center (NACC), the Alzheimer's Disease Neuroimaging Initiative (ADNI), and the Parkinson's Progression Markers Initiative (PPMI), among others.
By analyzing neuroimaging biomarkers, cognitive assessments, genetic risk factors, medical history, neurological exams, and demographic information, IGC Pharma's AI-driven approach enables a more precise and scalable diagnostic framework. Using state-of-the-art transformer-based neural networks, the model's architecture is designed to process diverse patient data while compensating for missing information-delivering reliable, personalized insights across different patient populations.
"The AI model is a potential game changer for our growth strategy. Our AI platform is a key driver of IGC Pharma's long-term growth strategy, reinforcing our commitment to precision medicine and targeted treatments for neurodegenerative diseases," said Ram Mukunda, CEO of IGC Pharma. "Misdiagnosis remains a significant challenge, often delaying treatment for patients who need it most. Our AI-driven model aims to close this gap, ultimately improving patient outcomes."
This initiative is part of IGC Pharma's broader AI strategy, positioning the company at the forefront of innovation in Alzheimer's research. The development of an AI foundation model for Alzheimer's disease and dementia detection represents a transformative step forward, not only in advancing medical breakthroughs but also in enhancing the Company's long-term value and leadership in AI-driven healthcare solutions.
About IGC Pharma (dba IGC):
IGC Pharma is an AI-powered, clinical-stage biotechnology company focused on developing innovative treatments for Alzheimer's disease and transforming patient care with fast-acting, safe, and effective solutions. Our portfolio includes the TGR family, including TGR-63, which targets amyloid plaques, a hallmark of Alzheimer's. The IGC-C and IGC-M platforms are advancing in preclinical studies, focusing on metabolic disorders, tau proteins, early plaque formation, and multiple disease hallmarks. Our lead therapeutic candidate, IGC-AD1, is a cannabinoid-based treatment currently in a Phase 2 trial for agitation in dementia ("CALMA") associated with Alzheimer's (clinicaltrials.gov, IGC Pharma Phase II). Interim data for IGC-AD1 demonstrated that it has the potential to transform patient care by offering faster-acting and more effective relief compared to traditional medications. Additionally, our AI models are designed to predict potential biomarkers for the early detection of Alzheimer's, optimize clinical trials, and predict receptor affinity, among others. With 32 patent filings and a commitment to innovation, IGC Pharma is dedicated to advancing pharmaceutical treatments and improving the lives of those affected by Alzheimer's and related conditions. The Company operates a wellness brand offering scientifically formulated products under the brand Holiby™ and as white-labeled formulations.
Forward-Looking Statements
This press release contains forward-looking statements. These forward-looking statements are based largely on IGC Pharma's expectations and are subject to several risks and uncertainties, certain of which are beyond IGC Pharma's control. Actual results could differ materially from these forward-looking statements as a result of, among other factors, the Company's failure or inability to commercialize one or more of the Company's products or technologies, including the products or formulations described in this release, or failure to obtain regulatory approval for the products or formulations, where required, or government regulations affecting AI or the AI algorithms not working as intended or producing accurate predictions; general economic conditions that are less favorable than expected; the FDA's general position regarding cannabis- and hemp-based products; and other factors, many of which are discussed in IGC Pharma's U.S. Securities and Exchange Commission ("SEC") filings. IGC incorporates by reference its Annual Report on Form 10-K filed with the SEC on June 24, 2024, and on Form 10-Q filed with the SEC on August 7, 2024, as if fully incorporated and restated herein. Considering these risks and uncertainties, there can be no assurance that the forward-looking information contained in this release will occur.
SOURCE: IGC Pharma, Inc.
View the original press release on ACCESS Newswire
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
a day ago
More women get Alzheimer's than men. It may not just be because they live longer
Working three full-time jobs, raising kids and tending her blooming garden: Angeleta Cox says her mother, Sonia Elizabeth Cox, never really slowed down all her life. Then, at the age of 64, a diagnosis of Alzheimer's slammed the brakes on the vibrant life she'd painstakingly built after immigrating to Canada from Jamaica in 1985. The onset of the symptoms came on very fast, Cox said of her mother. She forgot my dad first, and she wasn't able to respond to my brother, so I became a care provider for her, said Cox. Sonia Elizabeth died late last year, after years of battling Alzheimer's. More women get diagnosed with Alzheimer's disease than men. In developed countries, studies (new window) suggest (new window) about two-thirds of people with Alzheimer's are women. It's a pattern seen in Canada, too, where women account for almost two-thirds of people with dementia, according to the last count from Statistics Canada (new window) . Scientists long explained this with a simple demographic fact: women tend to live longer, and age is a strong risk factor for the development of dementia. But that understanding is now changing. While age is still considered an important risk, scientists are increasingly realizing other aspects — both biological and sociological — may play an important role in making women susceptible to developing Alzheimer's. WATCH | Alzheimer's in women linked to early menopause, say scientists: I think we're beginning to be at an inflection point, said Gillian Einstein, who studies how sex and gender can influence an individual's risk for developing dementia, as part of the Canadian Consortium on Degeneration and Aging. I think you can feel it here, she said, gesturing around at the Metro Toronto Convention Centre, where leading Alzheimer's researchers gathered for the annual Alzheimer's Association International Conference (AAIC) in late July. There's so many more sessions on sex differences, or women's health. Hormones, babies and menopause Alzheimer's disease is the most common form (new window) of dementia in the world, according to the World Health Organization. It causes symptoms like memory loss, confusion and personality changes. In Canada, Alzheimer's is also the ninth leading cause of death, according to Statistics Canada (new window) . One factor scientists now know about: the timing of key hormonal changes, like when women first get their periods, how long they are fertile for, and the age they reach menopause. There are a lot of studies in the UK Biobank, for example, showing that the longer the reproductive [period] women have, the lower the risk is of late-life Alzheimer's disease. Having [one to] three children also seems to lower the risk of Alzheimer's, said Einstein, referring to a large database containing the health and genetic information from 500,000 volunteers. Enlarge image (new window) Gillian Einstein studies women's brain health and aging at the University of Toronto. She says scientists are at an inflection point in understanding gender and sex risks for Alzheimer's disease Photo: CBC News / Ken Townsend Premature menopause, which happens before the age of 40, and early menopause (between the ages of 40 and 44) are also key risk factors, said Dr. Walter Rocca, who studies the differences in the way men and women age at the Mayo Clinic in Rochester, Minn. So these women should be treated appropriately to avoid these deficiency of hormones, said Rocca, who presented research on the topic at the AAIC conference. What that treatment looks like could vary widely, Rocca said, based on the patient, as well as the cost and availability of the drug. Some main treatment approaches include pills, patches, gels and creams containing the hormone estrogen, which has been shown to have neuroprotective effects but naturally declines during menopause. The risk of cognitive decline with early or premature menopause exists whether the menopause happened naturally, or caused by their ovaries being removed, says Einstein. She pointed to a study (new window) she co-authored, which analyzed data from over 34,000 women from the UK Biobank. Women who had their ovaries removed prior to the age of 50 will also have an increased risk of Alzheimer's, she said. More inclusive research Researchers are playing catch-up, when it comes to understanding women's risk for Alzheimer's, says Natasha Rajah, a Tier 1 Canada Research Chair in Sex, Gender and Diversity in Brain Health, Memory and Aging at Toronto Metropolitan University. Not only have we not been included in the research, but even in the clinical trials, we're not represented, she said. It makes no sense when you think this disease affects more females than males. She's hoping to fill in some of those blanks. She's currently conducting the Canadian Brain Health at Midlife and Menopause study (BHAMM), which searches for early signs of the disease through brain scans and blood samples at mid-life. We're trying to understand whether or not menopause is a window at which some females might be showing early signs of Alzheimer's disease, she said. Enlarge image (new window) Scientists are playing catch up in understanding sex and gender-related risks for Alzheimer's disease, says Natasha Rajah, a Tier 1 Canada Research Chair in Sex, Gender and Diversity in Brain Health, Memory and Aging at Toronto Metropolitan University. Photo: CBC News / Pelin Sidki If they are identifiable, those showing early signs of disease could get treatment or alter their lifestyles to better age, according to Rajah. There is no cure for Alzheimer's, but treatments include drugs (new window) that can help manage symptoms. Lifestyle changes, like physical exercise and a brain-healthy diet have also been shown to help (new window) brain health in older adults at risk of cognitive decline. She's also hoping to capture a more diverse population group in her research to better understand risk factors associated with race. Alzheimer's research in Western countries like the U.S. and Canada hasn't always been diverse, says Rajah. With the BHAMM study, we're trying to reach out to as many communities as possible because we want to be more representative in our research. Different choices Looking back, Cox says she now realizes surgically induced menopause was a risk factor for her mother, who had a full hysterectomy after having fibroids in her 30s. The knowledge has led her to make different choices for herself — like reducing stress and taking care of her mental health. She's also now aware of how her own hormones can interact with Alzheimer's risk. Enlarge image (new window) Sonia Elizabeth Cox died in late 2024, after a years-long battle with Alzheimer's. Angeleta Cox says she thinks of her mother every time she looks at the garden Sonia once lovingly tended. Photo: Submitted by Angeleta Cox When it came time for me to deal with my fibroids that I had, I chose not to have a full hysterectomy. She's also passing down the knowledge to her daughter — and sharing it with other members of the Black community who have been impacted by Alzheimer's, through the Pan African Dementia Association. She's hoping researchers will find out more about risk factors for women developing Alzheimer's — so fewer women and families have to live through what her mom did. When it impacts women, it impacts the entire family and the community, she said. Jennifer Yoon (new window) · CBC News · Senior Health Reporter Jennifer Yoon covers the latest health news for CBC News on television, radio and digital. You can reach her at
Cision Canada
a day ago
- Cision Canada
Antimony Mining Market Experiencing Rapid Growth as a Result of Growing Demand Across Various Sectors
NEW YORK, Aug. 11, 2025 /CNW/ -- Industry insiders say that the global demand for Antimony market is expected to continue growing for several years to come. Some key uses of antimony include: Antimony alloys improve the durability of lead-acid batteries in military vehicles; Its flame-retardant properties enhance the fire resistance of military uniforms and equipment; and it is used in semiconductors for infrared sensors and night-vision devices. These are crucial for defense technology. A 2025 report from Research and Markets revealed the antimony market size is expected to see strong growth in the next few years. It will grow to $6.54 billion in 2029 at a compound annual growth rate (CAGR) of 6.9%. The growth in the forecast period can be attributed to advanced electronics, EV revolution, stringent regulations, global economic conditions, exploration and mining developments. Major trends in the forecast period include green technologies, battery technologies, market expansion in Asia-Pacific, shift towards sustainable antimony production, supply chain challenges and price volatility. The anticipated growth of the antimony market is attributed to the escalating number of fire accidents and the implementation of rigorous fire safety regulations. According to these regulations, prioritizing prevention is crucial to averting fire-related incidents. The surge in fire accidents has led to an increased demand for fire safety measures, consequently driving up antimony production. Antimony is commonly utilized as a flame inhibitor in fire-resistant apparel, flame retardants, and various fire protection systems. For example, in November 2023, reports from the National Fire Protection Association (NFPA), a non-profit organization based in the United States, revealed that in 2022, local fire departments in the U.S. responded to 1.5 million fire accidents. These incidents resulted in the loss of 3,790 lives, with 13,250 individuals sustaining injuries. The property damage from these fires is estimated to be $18 billion. Moreover, between 2021 and 2022, apartment fire-related deaths increased by 14%, injuries by 7%, and property losses by 6%. Consequently, the surge in fire incidents and the enforcement of stringent fire safety regulations are key drivers for the antimony market." Active mining companies active in markets currently include: Xtra Energy Corporation (OTCPK: XTPT), United States Antimony Corporation (NYSE American: UAMY), Perpetua Resources Corp. (NASDAQ: PPTA), MP Materials Corp. (NYSE: MP), Dateline Resources Limited (OTCQB: DTREF). Research and Markets also added in a separate article: "North America and Europe, together accounting for over 40% share of the global Antimony demand in 2024, are the other major markets. The main applications for Antimony in these regions are centered around the automotive and plastics industries. However, these markets are also characterized by stringent industrial regulatory and safety standards in the areas of environmental and personnel protection, which has put brakes on further demand for the element and its compounds. Recycling of old lead acid batteries to obtain antimony has been an effective strategy to curb ecological harm in these markets, a trend that is now catching up in other regions, too." Major Antimony Deposit Discovered: American Antimony Corporation - Operating as Xtra Energy Corporation (OTCPK: XTPT) - Confirms Thick, High-Grade Antimony-Gold Dike System at Arrance Mine - Xtra Energy Corporation ($XTPT), a U.S. based company dedicated to securing antimony, a critical mineral vital to national security for its use in defense, semiconductors, and energy storage, is pleased to provide its preliminary drilling report from the Arrance Mine, part of the flagship 4,194 acre American Antimony Project in Nevada's historic Bernice Canyon District. Investors are cautioned that these results are preliminary, based primarily on visual logging and portable XRF field analysis, and remain subject to confirmation by certified third-party laboratory assays. Samples have been delivered to American Assay Laboratories in Reno, Nevada, and final results will be released following analysis and review by Company geologists. Program Overview - The initial Arrance Mine drilling program consisted of five reverse circulation (RC) drill holes targeting the main felsite dike structure. Of the five holes drilled, four intersected significant stibnite mineralization, and three holes also returned notable gold values from portable XRF screening. The work confirms the presence of a thick, steeply dipping, stibnite-bearing felsite dike system with encouraging gold credits. Drill Highlights: Hole BC25-03 – "Spectacular Intercept" - Same pad as BC25-02; drilled at –20° dip; Dike intercept: 340–625 ft (285 ft continuous); Strong stibnite mineralization throughout; intense alteration; Visible gold confirmed in both high-grade intervals; Arsenic levels are low and well below deleterious thresholds; Preliminary geometry: ~630 ft downhole (~500 ft vertical); Gold (pXRF): 10 ft @ ~80.5 g/t Au (520–530 ft), including 5 ft @ 107 g/t Au; 5 ft @ 190 g/t Au (565–570 ft) Hole BC25-04 – South Step-Out - Located ~150 ft (50 m) south of BC25-02/03; Dike intercept: 110–145 ft (35 ft); Visual Sb present; represents southern strike continuity of the dike Hole BC25-05 – True Width Confirmation - Drilled between BC25-02 and BC25-03, opposite azimuth to measure true width; Dike intercept: 440–465 ft (25 ft); Widespread disseminated stibnite and strong alteration; Estimated true width: 30–45 ft (9–14 m) Hole BC25-01 – Northern Periphery Test - Encountered felsite dikes at 30–65 ft and 205–225 ft; No significant visible stibnite; interpreted as peripheral alteration zone Key Points - Drilling confirms a thick, steeply dipping, stibnite-bearing felsite dike at Arrance Mine; True width estimated at 30–45 ft (9–14 m); Apparent down-dip continuity of 285 ft in BC25-03, one of the thickest such intercepts documented in a U.S. Sb system in decades; Bonanza-grade gold (107 g/t and 190 g/t Au) in distinct zones within the dike; Low arsenic levels (<10–50 ppm pXRF) support favorable metallurgy "The results from Arrance are extremely exciting," said Mac J. Shahsavar, Chairman & CEO of Xtra Energy. "We have confirmed both the thickness and continuity of the mineralized dike, with visible stibnite and exceptionally low arsenic, plus the added benefit of bonanza gold zones. This combination of scale, grade, and metallurgy is rare in antimony systems. Inspired by recent government support for critical mineral projects, such as the U.S. Department of Defense's multibillion-dollar investment in MP Materials and the $24.8 million award to Perpetua Resources for antimony processing with FAST-41 permitting support, we look forward to advancing the Arrance project toward defining a domestic, world-class critical mineral resource that has the ability to help the U.S. with its national security interests." CONTINUED… Read this and more news for XTPT at: In other mining developments and happenings in the markets include: United States Antimony Corporation (NYSE American: UAMY) recently announced that it has completed an acquisition of 100% of the ownership interest of the Fostung Properties which cover fifty (50) single-cell mining claims or 1,114 hectares located approximately 70 kilometers west-southwest of Sudbury, Ontario, Canada, near the town of Espanola. The total purchase price of the tungsten properties was $5 Million in cash in addition to a ½ of 1% (0.005) Net Smelter Return royalty (NSR) interest to be divided equally between the sellers; Transition Metals Corp (XTM-V) and 1930153 ON Ltd (a Private Company). There exists an additional NSR of 1% (0.010) held by a previous owner. Recently, U.S. Secretary of Labor Lori Chavez-DeRemer and Idaho Governor Brad Little met with Perpetua Resources Corp. (NASDAQ: PPTA) in Valley County, Idaho to discuss the Stibnite Gold Project's strategic importance to the United States and Perpetua's plans to provide family-wage, in-demand jobs to rural Idaho during the construction and operations of the Stibnite Gold Project. During the visit, Perpetua Resources announced a new education and job training partnership with the College of Western Idaho (CWI). The Secretary's visit underscores the Trump administration's focus on domestic critical mineral projects that are essential to U.S. national security, like the Stibnite Gold Project. The Stibnite Gold Project is designed to restore the environment, provide family-wage jobs to rural Idaho, and produce gold and the critical mineral antimony. The Stibnite Gold Project, which was identified as a "Transparency Project" by the National Economic Development Council, is expected to provide the United States its only domestically mined source of the critical mineral antimony. Given antimony's essential role in hundreds of defense applications, the Department of Defense has granted Perpetua Resources more than $80 million to date to advance the Stibnite Gold Project. MP Materials Corp. (NYSE: MP) recently announced a definitive, long-term agreement to supply Apple with rare earth magnets manufactured in the United States from 100 percent recycled materials. Under the agreement, MP Materials will supply Apple with magnets produced at its Fort Worth, Texas, facility—known as Independence —using recycled rare earth feedstock processed at MP's Mountain Pass site in California. The feedstock will be sourced from post-industrial and end-of-life magnets, marking a major milestone in both companies' long-standing efforts to create sustainable, domestic supply chains. For nearly five years, Apple and MP Materials have been piloting advanced recycling technology that enables recycled rare earth magnets to be processed into material that meets Apple's exacting standards for performance and design. Building on this technical collaboration, MP will construct a commercial-scale, dedicated recycling line at Mountain Pass enabling the processing of a range of inputs, including magnet scrap and components recovered from end-of-life products. Dateline Resources Limited (OTCQB:DTREF), a North American-focused mining and exploration company, recently announced the appointment of Mr. Simon Slesarewich as Chief Operating Officer (COO), effective August 4, 2025. Mr. Slesarewich brings more than 25 years of international experience in project development, operations, and executive leadership across a range of commodities including gold, base metals, industrial minerals, and bulk commodities. In his new role, he will lead the development of Dateline's 100%-owned Colosseum Gold and Rare Earth Elements (REE) Project, located in California. "We are thrilled to have Simon join Dateline as our Chief Operating Officer at this pivotal stage for the Company," said Stephen Baghdadi, Managing Director of Dateline Resources. "Simon's decision to come on board, and his significant personal shareholding in Dateline, is a strong vote of confidence in the Colosseum Project and our vision. He brings a wealth of operational experience and a proven track record in taking projects from study through to production. We are confident that his leadership will be instrumental in successfully delivering the Colosseum Gold & REE Project into production and driving significant growth for Dateline." DISCLAIMER: (MNU) is a third party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels. MNU is NOT affiliated in any manner with any company mentioned herein. MNU and its affiliated companies are a news dissemination solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security. MNU'S market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities. The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. All material included herein is republished content and details which were previously disseminated by the companies mentioned in this release. MNU is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks. For current services performed MNU was compensated twenty two hundred dollars for news coverage of the current press releases issued by Xtra Energy Corporation by the company. MNU HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE. This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and MNU undertakes no obligation to update such statements.
Toronto Star
a day ago
- Toronto Star
Caledonia Mining Corporation Plc: Caledonia approves quarterly dividend
ST HELIER, Jersey, Aug. 11, 2025 (GLOBE NEWSWIRE) — Caledonia Mining Corporation Plc ('Caledonia' or 'the Company') (NYSE AMERICAN: CMCL; AIM: CMCL; VFEX: CMCL) is pleased to announce that the board of directors has approved a quarterly dividend of 14 United States cents (US$0.14) on each of the Company's shares. The relevant dates relating to the dividend are as follows:
